# Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers

> **NCT07748702** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 76 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CKD-339
- **DRUG:** D311, D107

## Key facts

- **NCT ID:** NCT07748702
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-20
- **Primary completion:** 2026-10-06
- **Final completion:** 2026-10-12
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748702, "Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*